Top Markets
Coin of the day
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

688336
株式のランク #3341
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a... Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd functions as a biopharmaceutical enterprise operating in China. This company is thoroughly engaged in the full lifecycle of antibody-based medicines, from their initial research and development to their production and subsequent market introduction. Its current portfolio includes YISAIPU, a tumor necrosis factor inhibitor utilized for treating rheumatic ailments; Xenopax, a recombinant humanized anti-CD25 monoclonal antibody delivered via injection; and Cipterbin, an anti-HER2 monoclonal antibody. Furthermore, the organization is actively progressing novel treatments designed for autoimmune disorders, various cancers, and other health issues. Established in 2002, its main offices are situated in Shanghai, China.
株価
$6.27
時価総額
$5.62B
変化(1日)
-0.46%
変化(1年)
26.35%
CN
取引 Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336)

カテゴリー

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd(688336)の株式分割履歴
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd株(シンボル:688336)は合計で0回の株式分割を実施しました。
最新の株式分割はAug 26, 2026に行われました。
Aug 26, 2026より前に購入された688336株は、現在0688336株に相当します。
株式分割一覧
株式分割 分割比率 累積分割比率
提供された日付のデータは十分ではありません。
類似企業または競合他社の株式分割
企業 株式分割の回数 累積分割比率
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH